Elawyers Elawyers
Washington| Change

Washington v. Secretary of Health and Human Services, 19-1548 (2020)

Court: United States Court of Federal Claims Number: 19-1548 Visitors: 5
Judges: Brian H. Corcoran
Filed: Jun. 29, 2020
Latest Update: Jun. 29, 2020
Summary: In the United States Court of Federal Claims OFFICE OF SPECIAL MASTERS No. 19-1548V UNPUBLISHED INDIA WASHINGTON, Mother and Chief Special Master Corcoran Natural Guardian of Infant, Z.K., Filed: May 21, 2020 Petitioner, v. Special Processing Unit (SPU); Damages Decision Based on Proffer; SECRETARY OF HEALTH AND Tetanus Diphtheria acellular HUMAN SERVICES, Pertussis (Tdap) Vaccine; Shoulder Injury Related to Vaccine Respondent. Administration (SIRVA) Michael M. Bast, Michael M. Bast, PC, Brookly
More
    In the United States Court of Federal Claims
                                  OFFICE OF SPECIAL MASTERS
                                          No. 19-1548V
                                         UNPUBLISHED


    INDIA WASHINGTON, Mother and                              Chief Special Master Corcoran
    Natural Guardian of Infant, Z.K.,
                                                              Filed: May 21, 2020
                         Petitioner,
    v.                                                        Special Processing Unit (SPU);
                                                              Damages Decision Based on Proffer;
    SECRETARY OF HEALTH AND                                   Tetanus Diphtheria acellular
    HUMAN SERVICES,                                           Pertussis (Tdap) Vaccine; Shoulder
                                                              Injury Related to Vaccine
                        Respondent.                           Administration (SIRVA)


Michael M. Bast, Michael M. Bast, PC, Brooklyn, NY, for petitioner.

Darryl R. Wishard, U.S. Department of Justice, Washington, DC, for respondent.


                                DECISION AWARDING DAMAGES 1

        On October 3, 2019, India Washington, mother and natural guardian of infant
Z.K., filed a petition for compensation under the National Vaccine Injury Compensation
Program, 42 U.S.C. §300aa-10, et seq., 2 (the “Vaccine Act”). Petitioner alleges that
Z.K. suffered shoulder injury related to vaccine administration and a causation-in-fact
claim for a sterile abscess of the left arm. Petition at 10-12. The case was assigned to
the Special Processing Unit of the Office of Special Masters.

        On January 21, 2020, a ruling on entitlement was issued, finding Petitioner
entitled to compensation for a sterile abscess. On May 20, 2020, Respondent filed a
proffer on award of compensation (“Proffer”) indicating Petitioner should be awarded an
amount sufficient to purchase the annuity as described in paragraph II.A. of the Proffer.

1
  Because this unpublished decision contains a reasoned explanation for the action in this case, I am
required to post it on the United States Court of Federal Claims' website in accordance with the E-
Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of
Electronic Government Services). This means the decision will be available to anyone with access
to the internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to
redact medical or other information, the disclosure of which would constitute an unwarranted invasion of
privacy. If, upon review, I agree that the identified material fits within this definition, I will redact such
material from public access.
2
 National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755. Hereinafter, for
ease of citation, all “§” references to the Vaccine Act will be to the pertinent subparagraph of 42 U.S.C. §
300aa (2012).
Proffer at 2. In the Proffer, Respondent represented that Petitioner agrees with the
proffered award.
Id. Based on
the record as a whole, I find that Petitioner is entitled to
an award as stated in the Proffer.

       Pursuant to the terms stated in the attached Proffer, I award Petitioner an
amount sufficient to purchase the annuity contract described in Section II.A of
the Proffer. This amount represents compensation for all damages that would be
available under § 15(a).

       The clerk of the court is directed to enter judgment in accordance with this
decision. 3

IT IS SO ORDERED.


                                          s/Brian H. Corcoran
                                          Brian H. Corcoran
                                          Chief Special Master




3
  Pursuant to Vaccine Rule 11(a), entry of judgment can be expedited by the parties’ joint filing of notice
renouncing the right to seek review.


                                                      2
             IN THE UNITED STATES COURT OF FEDERAL CLAIMS
                        OFFICE OF SPECIAL MASTERS
__________________________________________
                                                     )
INDIA WASHINGTON, Mother and                         )
Natural Guardian of Infant, Z.K.,                    )
                                          )
               Petitioner,                )                  No. 19-1548V ECF
                                          )
                  v.                      )                  Chief Special Master Corcoran
                                          )
 SECRETARY OF HEALTH AND                  )
 HUMAN SERVICES,                          )
                                          )
                  Respondent.             )
__________________________________________)

                        RESPONDENT’S PROFFER OF DAMAGES

I.     Procedural History

       On October 3, 2019, India Washington (“petitioner”), filed a petition for compensation

under the National Vaccine Injury Compensation Act of 1986, 42 U.S.C. §§ 300aa-10 to -34

(“Vaccine Act” or “Act”), as amended. In that petition, petitioner alleged that her child, Z.K.

(hereinafter “ZK”), received a tetanus-diphtheria-acellular pertussis (“Tdap”) vaccination in the

left arm on March 5, 2018, and suffered a Table injury for shoulder injury related to vaccine

administration (“SIRVA”) and a causation-in-fact claim for a sterile abscess of the left arm. See

Petition (“Pet.”) at 1, 10-12. On January 15, 2020, petitioner filed an amended petition, alleging

only a causation-in-fact for the sterile abscess injury of the left arm. See Amended Pet. at 10-11.

On January 16, 2020, respondent filed his Vaccine Rule 4(c) report, conceding that petitioner

had satisfied all legal prerequisites for compensation under the Act for a causation-in-fact claim

for ZK’s sterile abscess. On January 21, 2020, the Chief Special Master issued a ruling on

entitlement, finding that petitioner was entitled to compensation for ZK.




                                                 1
II.       Items of Compensation and Form of the Award

          Based upon the evidence of record, respondent proffers, and the parties recommend, that

compensation be made through future annuity payments as described below, and request that the

Chief Special Master’s decision and the Court’s judgment award the following: 1

          A.      Annuity

          An amount sufficient to purchase an annuity contract, 2 paid to the life insurance

company3 from which the annuity will be purchased, 4 subject to the conditions described below,

that will provide payments to ZK as set forth below:

               1. $15,890.33 payable in a certain lump sum on 02/13/2035.
               2. $17,329.63 payable in a certain lump sum on 02/13/2038.
               3. $18,912.52 payable in a certain lump sum on 02/13/2041.




      1
     Should ZK die prior to entry of judgment, the parties reserve the right to move the Court for appropriate relief.
In particular, respondent would oppose any award for future medical expenses, future lost earnings, and future pain
and suffering.
      2
     In respondent’s discretion, respondent may purchase one or more annuity contracts from one or more life
insurance companies.
      3
     The Life Insurance Company must have a minimum of $250,000,000 capital and surplus, exclusive of any
mandatory security valuation reserve. The Life Insurance Company must have one of the following ratings from
two of the following rating organizations:

                  a. A.M. Best Company: A++, A+, A+g, A+p, A+r, or A+s;

                  b. Moody's Investor Service Claims Paying Rating: Aa3, Aa2, Aa1, or Aaa;

                  c. Standard and Poor's Corporation Insurer Claims-Paying Ability Rating: AA-, AA, AA+, or
                  AAA;

                  d. Fitch Credit Rating Company, Insurance Company Claims Paying Ability Rating: AA-, AA,
                  AA+, or AAA.
      4
     Petitioner authorizes the disclosure of certain documents filed by the petitioner in this case consistent with the
Privacy Act and the routine uses described in the National Vaccine Injury Compensation Program System of
Records, No. 09-15-0056.

                                                           2
Should ZK predecease any of the certain lump sum payments set forth above, said payments

shall be made to his estate. Written notice to the Secretary of Health and Human Services and to

the Life Insurance Company shall be provided within twenty (20) days of ZK’s death.

             This amount represents all elements of compensation to which ZK would be entitled

under 42 U.S.C. § 300aa-15(a). Petitioner agrees. 5


II.          Summary of Recommended Payments Following Judgment

             A.       An amount sufficient to purchase the annuity contract described
                      above in section I. A.

                                                                    Respectfully submitted,

                                                                    JOSEPH H. HUNT
                                                                    Assistant Attorney General

                                                                    C. SALVATORE D’ALESSIO
                                                                    Acting Director
                                                                    Torts Branch, Civil Division

                                                                    CATHARINE E. REEVES
                                                                    Deputy Director
                                                                    Torts Branch, Civil Division

                                                                    HEATHER L. PEARLMAN
                                                                    Assistant Director
                                                                    Torts Branch, Civil Division

                                                                    /s/Darryl R. Wishard
                                                                    DARRYL R. WISHARD
                                                                    Senior Trial Attorney
                                                                    Torts Branch, Civil Division
                                                                    U.S. Department of Justice
                                                                    P.O. Box 146
                                                                    Benjamin Franklin Station
                                                                    Washington, D.C. 20044-0146
                                                                    Tel: (202) 616-4357

             Dated: May 20, 2020

      5
          At the time payment is received, ZK will be an adult, and thus, a guardianship is not required.

                                                               3

Source:  CourtListener

Can't find what you're looking for?

Post a free question on our public forum.
Ask a Question
Search for lawyers by practice areas.
Find a Lawyer